本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vera Therapeutics, Inc.

22.70
-7.9300-25.89%
盘后22.60-0.1000-0.44%19:59 EDT
成交量:1,264.08万
成交额:2.74亿
市值:14.48亿
市盈率:-7.57
高:23.14
开:21.27
低:20.50
收:30.63
数据加载中...
2025/06/03

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/19

重要事件披露

Form 8-K - Current report
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]